Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25595637.
- Also identified by DOI 10.1016/S1473-3099(14)71071-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The epidemic of Ebola virus disease has spread at an alarming rate despite containment efforts. As a result, unprecedented large-scale international response efforts have been made in an attempt to gain control of the outbreak and reduce transmission. Several international consortia have been formed in a remarkable worldwide collaborative effort to expedite trials of two candidate Ebola virus vaccines: cAd3-EBOZ and rVSV-EBOV. In parallel, both vaccines are being manufactured in large amounts to enable future rapid deployment for management of the crisis.
Medical subject headings
- Disease Outbreaks
- Ebola Vaccines
- Ebolavirus
- Hemorrhagic Fever, Ebola